(BHVN)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

BHVN Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2022-10-31 Coric Vlad director, officer: Chief Executive Officer 1,543,394 P-Purchase A 25,800 15.97 411,995.04
2022-10-28 Coric Vlad director, officer: Chief Executive Officer 109,565 P-Purchase A 100,000 14.82 1,482,420.00
2022-10-28 Coric Vlad director, officer: Chief Executive Officer 1,517,594 P-Purchase A 41,930 14.87 623,352.34
2022-10-25 Coric Vlad director, officer: Chief Executive Officer 1,475,664 P-Purchase A 853,380 10.50 8,960,490.00
2022-10-25 Buten Matthew officer: Chief Financial Officer 166,653 P-Purchase A 142,857 10.50 1,499,998.50
2022-10-25 CHILDS JOHN W director 5,691,251 P-Purchase A 3,900,000 10.50 40,950,000.00
2022-10-25 Bailey Gregory director 1,507,971 P-Purchase A 200,000 10.50 2,100,000.00
2022-10-25 GREGORY JULIA P director 25,665 P-Purchase A 9,523 10.50 99,991.50
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 399,443 P-Purchase A 2,100 12.35 25,928.07
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 397,343 P-Purchase A 52,523 11.79 619,162.13
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 344,820 P-Purchase A 80,606 10.82 871,907.04
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 264,214 P-Purchase A 34,459 9.89 340,968.36
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 229,755 P-Purchase A 73,005 8.82 644,130.42
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 492,212 P-Purchase A 54,329 11.83 642,614.28
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 437,883 P-Purchase A 80,907 10.83 875,842.55
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 356,976 P-Purchase A 34,515 9.90 341,843.46
2022-10-05 Coric Vlad director, officer: Chief Executive Officer 322,461 P-Purchase A 73,331 8.82 647,028.75
2022-10-05 CHILDS JOHN W director 1,791,251 P-Purchase A 32,841 9.70 318,403.35
2022-10-05 CHILDS JOHN W director 1,758,410 P-Purchase A 241,300 8.88 2,142,768.13
2022-10-03 Conway Charles officer: Chief Scientific Officer 0 D-Return D 54,000 9.07 489,780.00
2022-10-03 Conway Charles officer: Chief Scientific Officer 0 D-Return D 54,000 9.07 489,780.00
2022-10-03 Conway Charles officer: Chief Scientific Officer 0 D-Return D 54,000 9.07 489,780.00
2022-10-03 Antonijevic Irina director 0 D-Return D 5,070 0.00 0.00
2022-10-03 Engelhart James officer: Strategic Advisor 0 D-Return D 83,792 9.07 759,993.44
2022-10-03 Engelhart James officer: Strategic Advisor 0 D-Return D 83,792 9.07 759,993.44
2022-10-03 Engelhart James officer: Strategic Advisor 0 D-Return D 83,792 9.07 759,993.44
2022-10-03 Engelhart James officer: Strategic Advisor 0 D-Return D 83,792 9.07 759,993.44
2022-10-03 Tilton John officer: Chief Commercial Officer 0 D-Return D 37,292 9.07 338,238.44
2022-10-03 Tilton John officer: Chief Commercial Officer 0 D-Return D 37,292 9.07 338,238.44
2022-10-03 Tilton John officer: Chief Commercial Officer 0 D-Return D 37,292 9.07 338,238.44
2022-10-03 Tilton John officer: Chief Commercial Officer 1,614 D-Return D 5,068 148.50 752,598.00
2022-10-03 GREGORY JULIA P director 0 D-Return D 18,000 60.24 1,084,320.00
2022-10-03 Mehta Kishan director 0 D-Return D 20,000 36.64 732,800.00
2022-10-03 Mehta Kishan director 0 D-Return D 20,000 36.64 732,800.00
2022-10-03 Mehta Kishan director 0 D-Return D 20,000 36.64 732,800.00
2022-10-03 Buten Matthew officer: Chief Financial Officer 0 D-Return D 22,900 125.69 2,878,301.00
2022-10-03 Buten Matthew officer: Chief Financial Officer 0 D-Return D 22,900 125.69 2,878,301.00
2022-10-03 Buten Matthew officer: Chief Financial Officer 0 D-Return D 22,900 125.69 2,878,301.00
2022-10-03 Heffernan Michael Thomas director 0 D-Return D 26,200 47.30 1,239,260.00
2022-10-03 Heffernan Michael Thomas director 0 D-Return D 26,200 47.30 1,239,260.00
2022-10-03 Heffernan Michael Thomas director 15,178 F-InKind D 9,699 7.50 72,742.50
2022-10-03 HUGIN ROBERT J director 12,959 F-InKind D 12,959 7.50 97,192.50
2022-10-03 Coric Vlad director, officer: Chief Executive Officer 569,309 J-Other A 0 0.00 0.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 300,000 A-Award A 300,000 7.00 2,100,000.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 0 M-Exempt A 12,500 0.54 6,750.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 0 M-Exempt A 12,500 0.54 6,750.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 0 M-Exempt A 12,500 0.54 6,750.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 12,500 J-Other A 12,500 0.54 6,750.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 4,500 J-Other A 4,500 1.86 8,370.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 20,716 J-Other A 20,716 1.03 21,337.48
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 295 J-Other A 295 1.03 303.85
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 1,542 J-Other A 1,542 1.61 2,482.62
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 30,958 J-Other A 30,958 1.61 49,842.38
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 3,000 J-Other A 3,000 2.52 7,560.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 14,000 J-Other A 14,000 2.84 39,760.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 13,801 J-Other A 13,801 4.13 56,998.13
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 1,199 J-Other A 1,199 4.13 4,951.87
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 12,612 J-Other A 12,612 6.37 80,338.44
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 387 J-Other A 387 6.37 2,465.19
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 95,969 F-InKind D 37,492 7.00 262,444.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 133,461 M-Exempt A 12,500 0.54 6,750.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 120,961 M-Exempt A 4,500 1.86 8,370.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 116,461 M-Exempt A 20,716 1.03 21,337.48
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 95,745 M-Exempt A 295 1.03 303.85
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 95,450 M-Exempt A 1,542 1.61 2,482.62
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 93,908 M-Exempt A 30,958 1.61 49,842.38
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 62,950 M-Exempt A 3,000 2.52 7,560.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 59,950 M-Exempt A 14,000 2.84 39,760.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 45,950 M-Exempt A 13,801 4.13 56,998.13
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 32,149 M-Exempt A 1,199 4.13 4,951.87
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 30,950 M-Exempt A 12,612 6.37 80,338.44
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 18,338 M-Exempt A 387 6.37 2,465.19
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 17,951 J-Other A 1,875 0.00 0.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 16,076 J-Other A 3,750 0.00 0.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 12,326 J-Other A 6,500 0.00 0.00
2022-10-03 Gentile Kimberly officer: SVP, Clinical Operations 5,826 J-Other A 5,826 0.00 0.00
2022-10-03 Heffernan Michael Thomas director 125,000 A-Award A 125,000 7.00 875,000.00
2022-10-03 Heffernan Michael Thomas director 0 M-Exempt A 13,100 2.40 31,440.00
2022-10-03 Heffernan Michael Thomas director 13,100 J-Other A 13,100 2.40 31,440.00
2022-10-03 Heffernan Michael Thomas director 5,998 J-Other A 5,998 3.56 21,352.88
2022-10-03 Heffernan Michael Thomas director 4,119 J-Other A 4,119 4.84 19,935.96
2022-10-03 Heffernan Michael Thomas director 19,370 F-InKind D 5,507 7.50 41,302.50
2022-10-03 Heffernan Michael Thomas director 24,877 M-Exempt A 13,100 2.40 31,440.00
2022-10-03 Heffernan Michael Thomas director 11,777 M-Exempt A 5,998 3.56 21,352.88
2022-10-03 Heffernan Michael Thomas director 5,779 M-Exempt A 4,119 4.84 19,935.96
2022-10-03 Heffernan Michael Thomas director 1,660 J-Other A 1,660 0.00 0.00
2022-10-03 CHILDS JOHN W director 5,000 J-Other A 5,000 0.00 0.00
2022-10-03 CHILDS JOHN W director 1,517,110 J-Other A 1,512,500 0.00 0.00
2022-10-03 Coric Vlad director, officer: Chief Executive Officer 9,565 J-Other A 9,565 0.00 0.00
2022-10-03 Coric Vlad director, officer: Chief Executive Officer 156,750 J-Other A 156,750 0.00 0.00
2022-10-03 Coric Vlad director, officer: Chief Executive Officer 249,130 J-Other A 249,130 0.00 0.00
2022-10-03 Coric Vlad director, officer: Chief Executive Officer 622,284 J-Other A 46,025 0.00 0.00
2022-10-03 CHILDS JOHN W director 0 D-Return D 11,996 70.17 841,759.32
2022-10-03 CHILDS JOHN W director 0 D-Return D 11,996 70.17 841,759.32
2022-10-03 HUGIN ROBERT J director 0 D-Return D 18,948 66.88 1,267,242.24
2022-10-03 HUGIN ROBERT J director 0 D-Return D 18,948 66.88 1,267,242.24
2022-10-03 HUGIN ROBERT J director 0 D-Return D 18,948 66.88 1,267,242.24
2022-10-03 JONES WILLIAM A JR officer: CCO-Migraine & Common Disease 0 D-Return D 44,087 49.47 2,180,983.89
2022-10-03 JONES WILLIAM A JR officer: CCO-Migraine & Common Disease 0 D-Return D 44,087 49.47 2,180,983.89
2022-10-03 JONES WILLIAM A JR officer: CCO-Migraine & Common Disease 0 D-Return D 44,087 49.47 2,180,983.89

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.